Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MELI | ITUB |
|---|---|---|
| Price | $1,744.94 | $8.06 |
| Change today | ▼ 3.02% | ▼ 1.53% |
| Market cap | $88.46B | $88.78B |
| Return, 3 months | +5.1% | +2.4% |
| Return, year to date | -13.4% | +14.9% |
| Return, 1 year | -30.5% | +23.1% |
| P/E (TTM) | 47.5 | 9.9 |
| P/B | 11.3 | 2.1 |
| P/E percentile vs own 5y | 13th | 78th |
| Dividend yield | – | 7.44% |
| Revenue growth (YoY, latest qtr) | +49.8% | +14.6% |
| Net profit growth (YoY) | -10.9% | +8.1% |
| Gross margin | 42.7% | – |
| Operating margin | 8.3% | – |
| Net margin | 5.3% | 27.7% |
| Return on equity | 27.5% | 22.0% |
| Analyst target vs. price | +29.9% | +24.1% |
| Analyst buy share | 78% | 100% |
| RSI (14) | 41 | 60 |
| 30-day volatility | 37.7% | 29.2% |
| Max drawdown, 1 year | -38.4% | -23.6% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.